Cumulus Cell Mitochondrial Activity as a Non-invasive Marker of Embryo Quality (FLIM)
Cumulus Cell Mitochondrial Activity as a Non-invasive Marker of Embryo Quality
Sponsor: Harvard University Faculty of Medicine
Listed as NCT05332769, this observational or N/A phase trial focuses on Cumulus Cell and Fluorescence Lifetime Imaging Microscopy and remains ongoing. Sponsored by Harvard University Faculty of Medicine, it has been updated 9 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting
-
Jun 2025 — Sep 2025 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jan 2025 — Jun 2025 [monthly]
Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Apr 2024 — Jul 2024 [monthly]
Recruiting
-
Oct 2023 — Apr 2024 [monthly]
Recruiting
-
Jul 2022 — Oct 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
May 2022 — Jul 2022 [monthly]
Not Yet Recruiting
First recorded
Apr 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Harvard University Faculty of Medicine
- Hospital Foch, Suresnes, France.
- Mỹ Đức Hospital
- The Needleman Lab, Northwest Lab Building 359,52 Oxford Street Cambridge MA 02138.
For direct contact, visit the study record on ClinicalTrials.gov .